Cosmo Pharmaceuticals N.V. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ARGX | argenx | Outperform |
4
|
363.10€ | 531.81€ | 20.63% | 10 | 21.56€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.95k | kr2.71k | 35.66% | 14 | kr125.84B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
50.20€ | 48.61€ | 2.49% | 1 | 10.30€B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr619.50 | kr357.00 | 31.56% | 2 | kr39.42B |
| ORNBV | Orion Oyj | Hold |
14
|
35.68€ | 42.52€ | 17.71% | 3 | 5.04€B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.25 | £28.11 | 51.74% | 9 | £4.27B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr131.00 | kr109.25 | 1.53% | 3 | kr28.87B |
| ALKS | Alkermes | Outperform |
10
|
$23.86 | $33.27 | 34.12% | 3 | $4.06B |
| MOR | MorphoSys | Outperform |
6
|
66.10€ | 28.78€ | 2.87% | 3 | 2.49€B |
| INDV | Indivior PLC | Buy |
14
|
£14.40 | £28.89 | 116.94% | 4 | £1.95B |
| ALM | Almirall | Outperform |
16
|
8.66€ | 11.39€ | 27.02% | 3 | 1.79€B |
| EVT | Evotec | Outperform |
14
|
9.90€ | 37.33€ | 157.58% | 4 | 1.73€B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.27 | $41.00 | 32.14% | 0 | $1.65B |
| FAE | Faes Farma | Hold |
18
|
3.45€ | 3.90€ | 5.80% | 0 | 1.06€B |
| PHM | Pharma Mar | Outperform |
13
|
30.92€ | 50.20€ | 55.24% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF39.60 | CHF65.63 | 66.67% | 0 | CHF474.13M |
| DBV | DBV Technologies | Outperform |
5
|
1.22€ | 4.07€ | 227.87% | 1 | 119.69€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.32 | CHF9.50 | 181.63% | 1 | CHF110.77M |
| ASRT | Assertio Holdings | Buy |
8
|
$1.01 | $3.50 | 197.03% | 2 | $88.49M |
| DRRX | DURECT | Outperform |
9
|
$0.99 | $6.75 | 581.82% | 2 | $28.93M |